You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
四川雙馬(000935.SZ):控股子公司湖北健翔獲得出口歐盟證明文件

格隆匯7月30日丨四川雙馬(000935.SZ)公佈,公司控股子公司湖北健翔生物製藥有限公司(簡稱“湖北健翔”)於近期收到了湖北省藥品監督管理局出具的《湖北省藥品GMP符合性檢查告知書》(編號:鄂GMP2025-95號)和《出口歐盟原料藥證明文件》(Written confirmation for active substances exported to EU,以下簡稱“WC證書”)(編號:HB250024)。湖北健翔A101車間A101生產線(原料藥利拉魯肽)經湖北省藥品監督管理局現場檢查,符合中國藥品GMP(即,藥品生產質量管理規範)的要求,等同於歐盟、世界衛生組織以及ICHQ7(即,國際人用藥品註冊技術協調會關於原料藥的藥品生產質量管理規範指南)藥品GMP要求。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account